Log In Request a Trial

Live Event on December 12th

Capitol Forum Health Care Competition Conference

Hear from FTC Commissioner Rebecca Slaughter, Jonathan Baron of Baron Public Affairs, Congressman Buddy Carter, the Department of Justice’s Michael Kades, and more thought leaders and industry experts on health care policy. 

RSVP

Capitol Forum Reporting, July 2024

Vance’s Letter to FTC on HSR Form Review

On July 18th, we published an article headlined “Vance’s Letter to FTC on HSR Form Review Suggests Interest in All-of-Government Approach to Competition, Even as Friends in Silicon Valley and the Republican Platform Call for Return to Laissez-faire Approach.” 

Read an Excerpt

Client Testimonials

See what our readers say about us.

Our global team of investigative reporters specializes in uncovering the truth behind market-moving issues and trends. Our journalists are experts at revealing key industry insights and actionable information.

Read More

Discover the Benefits of a Subscription

Our content provides subscribers with unique insight and breaking news regarding the most complex mergers and regulatory situations around the world.

Inquire

The Capitol Forum Advantage

Our work combines cutting edge breaking news with in-depth analysis to better inform readers how policy and regulation affects market competition.

Learn More

The Capitol Forum Community

Our editorial team reconstructs the policy process to yield market insight for a community of subscribers including government regulators, lawyers, investors, and non-profits.

Learn More

FEATURED ARTICLES

View all

Labor Thursday: FTC Cracks Down on Building Services Contractor’s No-Hire Agreement; Union Worker Charges Kroger and Albertsons with Colluding During Strike; Apple’s Employee Surveillance Under Fire; Amazon Contractors Win Preliminary Ruling to Begin Organizing, Amazon to Appeal; Aveanna Healthcare Faces Nurse Wage Suit

FTC orders building services contractor to cease no-hire agreement, saying...

Dec 05, 2024

Novo/Catalent: Buyer Negotiating Contract Extensions with Complaining Drugmakers

Novo Holdings is negotiating contract extensions with drugmakers complaining to...

Dec 03, 2024

Rio Tinto/Arcadium Lithium: Spokesperson for House Panel Monitoring China’s Rise Raises Concerns About Deal

Rio Tinto’s (RIO) attempted takeover of Arcadium Lithium (ALTM) is sparking...

Dec 02, 2024

RECENT PODCASTS

View all

Talking Big Tech, Antitrust, and Refusals to Deal with Daniel Hanley

Listen

Daniel Hanley, Senior Legal Analyst at the Open Markets Institute, discusses...

Nov 15, 2024

Market Concentration in Food & Agriculture with Sarah Carden and Basel Musharbash

Listen

Antitrust attorney Basel Musharbash and Farm Action’s Sarah Carden discuss a...

Oct 25, 2024

ABOUT THE CAPITOL FORUM

We are an investigative news organization providing our subscribers with detail-oriented reporting on antitrust, merger control, corporate investigations, and sector regulation.


COVERAGE

TESTIMONIALS

Barry Nigro - Partner and Antitrust Chair, Fried Frank

"The Capitol Forum’s articles include a good mix of investigative journalism combined with expert analysis and opinion."

Katrina Robson - Partner, Willkie Farr & Gallagher

"Capitol Forum’s comprehensive and diligent reporting on key competitive issues provides helpful insights on and contributes to the vigorous debate around antitrust policy and enforcement."

Mark Ostrau - Partner, Fenwick & West

"I rely on Capitol Forum daily for its valuable combination of timely information and unique insights on key deals and cases. It offers viewpoints and analyses that others don’t, which has become particularly valuable in the current policy environment."

Brendan Coffman - Partner, Wilson Sonsini Goodrich & Rosati

"Capitol Forum is a critical resource because it strikes a unique balance of reporting on breaking stories in antitrust, providing in-depth analysis, and offering a behind the scenes glimpse into the politics and personalities driving modern antitrust enforcement."

Kevin Hahm - Partner, Hunton Andrews Kurth

"I rely on Capitol Forum to get insight and analysis that’s often unavailable from other sources. Their coverage of FTC and DOJ matters is top-notch."

Barry Lynnn - Executive Director, Open Markets Institute

“The Capitol Forum is the only team covering this incredibly important beat. Better yet, their work is deeply intelligent, influential, and almost always right.”

Karl A. Racine - Former D.C. Attorney General

“I appreciate the helpful work done by The Capitol Forum. It’s one of the sources I turn to for information about what activity is out there not only in the antitrust space, but also in the consumer protection world.”

Bert Foer - Former President, American Antitrust Institute

“The Capitol Forum provides an always interesting and sometimes surprising look under the hood about pending antitrust activities.”

Melissa H. Maxman - Partner, Cohen & Gresser

“I have become an avid reader of The Capitol Forum because it provides timely in-depth news and analysis of the myriad legal, business, legislative and political factors affecting business developments. I always come away with fresh perspectives that help me advise my clients about current issues.”

David Witkin - CEO, Beryl Capital Management

“The Capitol Forum has been an indispensable resource for me in analyzing regulatory risk affecting companies in my portfolio or watch list.”

Allen Grunes - Shareholder, Brownstein Hyatt Farber Schreck

“The Capitol Forum consistently provides timely and sophisticated news and analysis of important M & A transactions. It’s the real deal!”

Ted Boettner - Senior Researcher, Ohio River Valley Institute

"Unlike most media outlets, The Capitol Forum digs deep into incredibly complex issues of great importance, providing timely and relevant analysis that you can use to inform your work."

RECENT ARTICLES | EDITOR'S PICKS

View all
Dec 05, 2024 Read Now >

RESOURCES

View all
Thank you for subscribing to our newsletter

SPECIAL REPORTS

View all

SPECIAL REPORT: Coordination Out Loud

Analysis of select corporate transcripts through the lens of Joseph Harrington’s landmark paper, “Collusion in Plain Sight: Firms’ use of Public Announcements to Restrain Competition.”

Sep 07, 2023 Read Now >

SPECIAL REPORT: Johnson & Johnson’s Remicade

Get an inside view of the biologics market, where rebate schemes appear to drive market share. You’ll learn how a complex system supports sluggish biosimilar uptake and other types of anticompetitive conduct. 

Sep 05, 2023 Read Now >

SPECIAL REPORT: Exclusive Drug Dealing

The Capitol Forum has recently published a special report with an extract of reporting that has been done analyzing price, market share and generic formulary exclusion data to spot anticompetitive conduct.

May 11, 2023 Read Now >